FDA Adverse Event Injury Summary report: N

STYLE 115 SILICONE GEL FILLED BREAST IMPLANT

MDR report key: 20076064 · Received August 27, 2024

Report

Report Number
9617229-2024-19653
Event Type
Injury
Date Received
August 27, 2024
Date of Event
June 10, 2024
Report Date
August 27, 2024
Manufacturer
ALLERGAN (COSTA RICA)
Product Code
FTR
PMA / PMN Number
P020056
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

DEVICE EVALUATION: DEVICE PHOTOGRAPH(S) FOR THE DEVICE RELATED TO THE REPORTED EVENT OF SEROMA WAS REVIEWED ON (B)(6), 2024. IT IS POSSIBLE TO DETERMINE THE LOT NUMBER 3113685 AND CATALOG NUMBER 115-290 OF THE PHOTOS PROVIDED. VISUAL ANALYSIS OF THE PHOTOGRAPHS IDENTIFIED: SEROMA: UNABLE TO OBSERVE. NO ADDITIONAL OBSERVATIONS WERE CARRIED OUT. NO FURTHER ACTIONS ARE REQUIRED AS NO MANUFACTURING ISSUES ARE OBSERVED.

Additional Manufacturer Narrative · 0

CONTINUED E1: PHONE NUMBER: (B)(6). A REVIEW OF THE DEVICE HISTORY RECORD HAS BEEN COMPLETED. NO DEVIATIONS OR NON-CONFORMANCES NOTED. THE EVENT OF SEROMA IS A PHYSIOLOGICAL COMPLICATION. AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN/WILL BE REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. REASON FOR REOPERATION: "LITTLE FLUID AROUND IMPLANT".

Description of Event or Problem · 0

HEALTHCARE PROFESSIONAL REPORTED RIGHT SIDE "LITTLE FLUID AROUND IMPLANT". THE DEVICE HAS BEEN EXPLANTED AND REPLACED.

Description of Event or Problem · 0

HEALTHCARE PROFESSIONAL REPORTED, RIGHT SIDE "LITTLE FLUID AROUND IMPLANT". THE DEVICE HAS BEEN EXPLANTED AND REPLACED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1219642 STYLE 115 SILICONE GEL FILLED BREAST IMPLANT PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED FTR ALLERGAN (COSTA RICA) 3113685

Patients

Seq Age Sex Outcome Treatment
1 63 YR Female Required Intervention